Francesc Corpas Lara (born in 1969) is ADIENNE’s Chief Commercial Officer. He began his career at Parke Davis and later at Aventis Spain where he developed several projects; the latest project was developed in the area of pharmaceuticals for severe and rare diseases. He also held several executive positions at SangStat Spain SL, an US biopharmaceutical company listed at the NASDAQ. As General Manager SangStat Spain SL., Francesc has contributed to solving the therapeutic and research needs in the area of transplant and has also executed several partnerships with pharmaceutical companies. He joined the company in 2005.